Clinical trials
Completed Hypertension trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
258 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 13 |
| 2008 | 11 |
| 2009 | 12 |
| 2010 | 14 |
| 2011 | 17 |
| 2012 | 22 |
| 2013 | 9 |
| 2014 | 22 |
| 2015 | 16 |
| 2016 | 10 |
| 2017 | 11 |
| 2018 | 13 |
| 2019 | 11 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 14 |
| 2023 | 13 |
| 2024 | 8 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 258 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chong Kun Dang Pharmaceutical | 44 |
| Boryung Pharmaceutical Co., Ltd | 35 |
| Hanmi Pharmaceutical Company Limited | 21 |
| Boehringer Ingelheim | 15 |
| Yuhan Corporation | 15 |
| AstraZeneca | 12 |
| Novartis Pharmaceuticals | 8 |
| Yonsei University | 8 |
| Daewoong Pharmaceutical Co. LTD. | 6 |
| Addpharma Inc. | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 258 |
| Dyslipidemias | 36 |
| Hyperlipidemias | 30 |
| Essential Hypertension | 19 |
| Diabetes Mellitus | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Hypercholesterolemia | 7 |
| Ischemic Stroke | 5 |
| Cardiovascular Diseases | 4 |
| Stroke | 4 |
Trials
Showing 1 to 25 of 258. Each trial links to its page on Pharma Observatory.
158 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.